Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,873
Closed -$348K 722
2023
Q4
$348K Sell
4,873
-1,831
-27% -$127K 0.03% 503
2023
Q3
$465K Sell
6,704
-2,235
-25% -$169K 0.04% 378
2023
Q2
$724K Buy
8,939
+333
+4% +$27.2K 0.06% 265
2023
Q1
$695K Sell
8,606
-603
-7% -$48.5K 0.06% 268
2022
Q4
$689K Sell
9,209
-15,152
-62% -$1.08M 0.07% 245
2022
Q3
$1.57M Sell
24,361
-14,241
-37% -$986K 0.17% 121
2022
Q2
$2.67M Buy
38,602
+1,977
+5% +$147K 0.28% 67
2022
Q1
$2.81M Buy
36,625
+2,875
+9% +$207K 0.25% 75
2021
Q4
$2.58M Buy
33,750
+9,848
+41% +$724K 0.17% 88
2021
Q3
$1.76M Buy
23,902
+12,993
+119% +$974K 0.12% 118
2021
Q2
$728K Sell
10,909
-1,403
-11% -$93.8K 0.05% 254
2021
Q1
$916K Sell
12,312
-1,614
-12% -$123K 0.07% 206
2020
Q4
$1.01M Buy
+13,926
New +$983K 0.08% 178
2016
Q3
Sell
-18,130
Closed -$628K 510
2016
Q2
$628K Buy
18,130
+813
+5% +$28.2K 0.08% 181
2016
Q1
$597K Sell
17,317
-448
-3% -$15.6K 0.08% 199
2015
Q4
$688K Sell
17,765
-1,199
-6% -$46.6K 0.08% 190
2015
Q3
$743K Buy
+18,964
New +$752K 0.1% 174

Other funds holding HOLX

Pitcairn's HOLX Position: Q1 2024 in Review

Pitcairn sold out of Hologic (HOLX) in Q1 2024, closing a stake of 4,873 shares — an estimated $348K sold.

Pitcairn first reported a position in HOLX in Q3 2015 and held it in 17 quarters. The position peaked at $2.81M in Q1 2022. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Pitcairn reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Pitcairn sold 4,873 Hologic shares in Q1 2024, an estimated $348K.
  • Pitcairn first reported a position in Hologic in Q3 2015 and held it in 17 quarters.
  • Pitcairn's Hologic position peaked at $2.81M in Q1 2022.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Pitcairn's 13F filing for Q1 2024, filed 13 May 2024.